Principal Investigator
Caitlin Hester
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20260129
Clinical Trial Summary
A Phase Ib Dose Escalation/Dose Expansion Study of PTM-101 as
an Adjunct to Neoadjuvant Therapy for Treatment Naïve,
Borderline Resectable and Locally Advanced Pancreatic Ductal
Adenocarcinoma (PDAC)
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Stomach and Esophageal Cancer
Contact Information
Phone Number
+1 (407) 7659589